EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
This Quarter Return
+15.67%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$2B
AUM Growth
+$2B
(+16%)
Cap. Flow
+$133M
Cap. Flow
% of AUM
6.62%
Top 10 Holdings %
Top 10 Hldgs %
28.16%
Holding
148
New
13
Increased
88
Reduced
14
Closed
14
Top Buys
| 1 |
Canadian Solar
CSIQ
|
$17.4M |
| 2 |
ATHN
Athenahealth, Inc.
ATHN
|
$17.1M |
| 3 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$16.6M |
| 4 |
Cirrus Logic
CRUS
|
$14.8M |
| 5 |
CAFD
8point3 Energy Partners LP Class A shares
CAFD
|
$12.7M |
Top Sells
| 1 |
DYAX
DYAX CORPORATION
DYAX
|
$27.7M |
| 2 |
CMRX
Chimerix, Inc.
CMRX
|
$20.4M |
| 3 |
SUNE
SUNEDISON, INC COM
SUNE
|
$20.3M |
| 4 |
TERP
TerraForm Power, Inc
TERP
|
$15.5M |
| 5 |
Cognex
CGNX
|
$7.05M |
Sector Composition
| 1 | Healthcare | 30.11% |
| 2 | Technology | 22.93% |
| 3 | Consumer Discretionary | 12.85% |
| 4 | Industrials | 7.77% |
| 5 | Real Estate | 4.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Sarepta Therapeutics
SRPT
$1.98B
| $12.8M | 0.64% |
332,300
+5,900
| +2% | +$228K |
|
|
XIFR
52
XPLR Infrastructure, LP
XIFR
$975M
| $12.6M | 0.63% |
423,750
+423,650
| +423,650% | +$12.6M |
|
|
AY
53
DELISTED
Atlantica Sustainable Infrastructure plc Ordinary Shares
AY
| $12.6M | 0.63% |
655,500
+653,800
| +38,459% | +$12.6M |
|
|
LLTC
54
DELISTED
Linear Technology Corp
LLTC
| $12.4M | 0.62% |
292,600
| – | – |
|
55
Acadia Pharmaceuticals
ACAD
$4.34B
| $11.9M | 0.6% |
334,700
+8,000
| +2% | +$285K |
|
56
EOG Resources
EOG
$65.8B
| $10.3M | 0.51% |
144,800
| – | – |
|
57
Ultragenyx Pharmaceutical
RARE
$3.04B
| $9.81M | 0.49% |
87,400
-18,100
| -17% | -$2.03M |
|
|
TSRO
58
DELISTED
TESARO, Inc.
TSRO
| $9.42M | 0.47% |
180,000
+12,000
| +7% | +$628K |
|
|
KITE
59
DELISTED
Kite Pharma, Inc.
KITE
| $9.16M | 0.46% |
148,600
+8,600
| +6% | +$530K |
|
|
DBVT
60
DBV Technologies
DBVT
$249M
| $9.06M | 0.45% |
249,600
+8,100
| +3% | +$294K |
|
|
AYR
61
DELISTED
Aircastle Limited
AYR
| $8.95M | 0.45% |
428,600
| – | – |
|
62
Ligand Pharmaceuticals
LGND
$3.25B
| $8.67M | 0.43% |
80,000
-33,500
| -30% | -$3.63M |
|
|
PEGI
63
DELISTED
Pattern Energy Group Inc. Class A
PEGI
| $8.55M | 0.43% |
408,950
+406,900
| +19,849% | +$8.51M |
|
64
Alnylam Pharmaceuticals
ALNY
$58.6B
| $8.47M | 0.42% |
90,000
+19,300
| +27% | +$1.82M |
|
65
BioMarin Pharmaceuticals
BMRN
$11.3B
| $7.86M | 0.39% |
75,000
-5,400
| -7% | -$566K |
|
|
SAGE
66
DELISTED
Sage Therapeutics
SAGE
| $7.34M | 0.37% |
125,900
+6,700
| +6% | +$391K |
|
|
CSLT
67
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
| $7.3M | 0.36% |
1,708,600
+925,000
| +118% | +$3.95M |
|
|
NTUS
68
DELISTED
Natus Medical Inc
NTUS
| $7.16M | 0.36% |
148,900
+12,900
| +9% | +$620K |
|
69
Prothena Corp
PRTA
$452M
| $7.14M | 0.36% |
104,800
+17,628
| +20% | +$1.2M |
|
70
Neurocrine Biosciences
NBIX
$13.5B
| $7.07M | 0.35% |
125,000
-121,100
| -49% | -$6.85M |
|
|
ONCE
71
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
| $6.8M | 0.34% |
150,000
+101,000
| +206% | +$4.58M |
|
72
Supernus Pharmaceuticals
SUPN
$2.52B
| $6.69M | 0.33% |
498,000
+149,400
| +43% | +$2.01M |
|
73
Celldex Therapeutics
CLDX
$1.57B
| $6.59M | 0.33% |
420,500
+191,700
| +84% | +$3.01M |
|
|
CERN
74
DELISTED
Cerner Corp
CERN
| $6.51M | 0.33% |
108,200
+6,600
| +6% | +$397K |
|
|
BPMC
75
DELISTED
Blueprint Medicines
BPMC
| $6.49M | 0.32% |
246,500
+139,500
| +130% | +$3.67M |
|